000 | 01896 a2200577 4500 | ||
---|---|---|---|
005 | 20250516003844.0 | ||
264 | 0 | _c20110621 | |
008 | 201106s 0 0 fre d | ||
022 | _a1768-3114 | ||
024 | 7 |
_a10.1016/j.patbio.2010.08.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPaugam, A | |
245 | 0 | 0 |
_a[Emergence of Candida parapsilosis candidemia at Cochin hospital. Characterization of isolates and search for risk factors]. _h[electronic resource] |
260 |
_bPathologie-biologie _cFeb 2011 |
||
300 |
_a44-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 |
_aAntifungal Agents _xadverse effects |
650 | 0 | 4 |
_aCandida _xdrug effects |
650 | 0 | 4 |
_aCandidemia _xepidemiology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCaspofungin |
650 | 0 | 4 |
_aCatheter-Related Infections _xepidemiology |
650 | 0 | 4 |
_aCross Infection _xepidemiology |
650 | 0 | 4 | _aDisease Susceptibility |
650 | 0 | 4 | _aDrug Resistance, Fungal |
650 | 0 | 4 |
_aDrug Utilization _xstatistics & numerical data |
650 | 0 | 4 |
_aEchinocandins _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHospitals, Public _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLipopeptides |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMorbidity _xtrends |
650 | 0 | 4 |
_aParis _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBaixench, M-T | |
700 | 1 | _aTaieb, F | |
700 | 1 | _aChampagnac, C | |
700 | 1 | _aDupouy-Camet, J | |
773 | 0 |
_tPathologie-biologie _gvol. 59 _gno. 1 _gp. 44-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.patbio.2010.08.009 _zAvailable from publisher's website |
999 |
_c20217253 _d20217253 |